Results 41 to 50 of about 146,053 (341)
Patient Preference and Adherence, 2023 Rano Kurnia Sinuraya,1– 3 Chalisma Wulandari,2 Riezki Amalia,2,3 Irma M Puspitasari2,3 1Unit of Global Health, Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 2Department of ...
Sinuraya RK +3 more
doaj
NSAID hypersensitivity – recommendations for diagnostic work up and patient management
Allergo Journal International, 2018 BackgroundAdverse drug reactions (ADR) to analgesics (i.e., non-steroidal anti-inflammatory drug hypersensitivity, NSAID-HS) are one of the most common ADR, affecting approximately 1.6% of all patients.
S. Wöhrl
semanticscholar +1 more source
Marshall Journal of Medicine, 2022 Introduction Over-the-counter (OTC) medications are commonly used by elderly patients to self-manage pain symptoms. Medications such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen and topical analgesics are readily available and ...
Courtney D. Wellman +5 more
doaj +1 more source
Forest plot of any NSAID versus non-NSAID users.
, 2014 Forest plot of any NSAID versus non-NSAID users.
Liaosha Ye (564240) +3 more
core +1 more source
, 2023 Risk of congenital malformations in infants following maternal exposure to NSAID during the first trimester compared with NSAID past users.
Eun-Young Choi (1758616) +8 more
core +1 more source
Intravenous ibuprofen - a novelty on the Polish pharmaceutical market [PDF]
Farmacja Polska, 2020 Ibuprofen, one of the most popular non-steroidal anti-inflammatory drugs in the world, went to treatment over 50 years ago. The drug is present in medicine in a wide range of doses and numerous drug forms for oral, rectal, and external administration. As
Marta Lewandowska, Katarzyna Dettlaff
doaj +1 more source
Forest plot of non-aspirin NSAID versus non-NSAID users.
, 2014 Forest plot of non-aspirin NSAID versus non-NSAID users.
Liaosha Ye (564240) +3 more
core +1 more source
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Drugs, 2015 Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid class with anti-inflammatory, analgesic, and antipyretic properties. Contrary to the action of many traditional NSAIDs, diclofenac inhibits cyclooxygenase (COX)-2 enzyme
R. Altman +4 more
semanticscholar +1 more source
International Journal of Pediatrics & Adolescent Medicine, 2020 Management of persistent patent ductus arteriosus (PDA) continues to be a challenging issue. The attitude toward PDA has shifted in the opposite direction during the last 20 years, from advocating an aggressive and early closure toward a call for ...
Jalal M. Abu-Shaweesh, Eyad Almidani
doaj +1 more source
, 2023 Background There are no prospective studies comparing how biological therapies affect nonsteroidal anti-inflammatory drug (NSAID) tolerance in NSAID-exacerbated respiratory disease.
Jorge Sánchez +4 more
core +1 more source